Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RASAGILINE

Ingredient

RASAGILINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-RASAGILINE	0.5MG	TABLET	Resolved	2017-03-11	2017-03-28	441
APO-RASAGILINE	0.5MG	TABLET	Resolved	2017-03-11	2017-03-28	438
APO-RASAGILINE	1MG	TABLET	Actual shortage	2025-10-10	2026-01-08	269320
APO-RASAGILINE	1MG	TABLET	Resolved	2023-11-17	2023-12-08	210743
APO-RASAGILINE	1MG	TABLET	Resolved	2023-03-16	2023-04-27	187244
APO-RASAGILINE	1MG	TABLET	Resolved	2021-12-17	2022-09-01	151367
APO-RASAGILINE	1MG	TABLET	Resolved	2020-10-21	2020-12-29	126777
APO-RASAGILINE	1MG	TABLET	Resolved	2020-06-24	2020-09-21	118775
APO-RASAGILINE	0.5MG	TABLET	Resolved	2017-06-27	2017-11-13	14011
APO-RASAGILINE	0.5MG	TABLET	Resolved	2019-06-12	2019-08-30	86327

1
2
3
Next

Showing 1 to 10 of 30

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
AZILECT	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258705
AZILECT	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258771
TEVA-RASAGILINE	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258753

1

Showing 1 to 3 of 3